A Study Evaluating the Efficacy of 5-FU + NALIRI and 5-FU + NALIRINOX for PDAC (NALPAC) (NALPAC)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05472259 |
|
Recruitment Status :
Recruiting
First Posted : July 25, 2022
Last Update Posted : July 27, 2022
|
Sponsor:
Belgian Group of Digestive Oncology
Collaborator:
University Hospital St Luc, Brussels
Information provided by (Responsible Party):
Belgian Group of Digestive Oncology
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | June 30, 2025 |
| Estimated Study Completion Date : | December 31, 2027 |